Literature DB >> 24193118

Lynch syndrome presenting as endometrial cancer.

Laura J Tafe1, Eleanor R Riggs, Gregory J Tsongalis.   

Abstract

BACKGROUND: Lynch syndrome (LS) is the most common form of the hereditary colon cancer syndromes. Because of its high prevalence, a nationwide campaign has begun to screen all colorectal cancers for the genetic abnormalities associated with LS. CONTENT: Next to colorectal cancer, endometrial cancer is the most common form of malignancy found in women with LS. Identifying individuals who harbor the well-characterized mismatch-repair gene mutations via immunohistochemistry, microsatellite instability analysis, or direct gene sequencing is critical to managing the LS patient and to surveillance for the development of other associated tumor types.
SUMMARY: Although many institutions have begun screening all colorectal tumors for LS, the evidence is sufficient to warrant the testing of all endometrial cancers for LS as well. Various testing algorithms, along with genetic-counseling efforts, can lead to a cost-efficient and beneficial screening program.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24193118     DOI: 10.1373/clinchem.2013.206888

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  12 in total

1.  Modern day screening for Lynch syndrome in endometrial cancer: the KEM experience.

Authors:  Nina Pauly; Thaïs Baert; Rita Schmutzler; Andreas du Bois; Stephanie Schneider; Kerstin Rhiem; Birgid Schömig-Markiefka; Janna Siemanowski; Sebastian Heikaus; Alexander Traut; Florian Heitz; Sonia Prader; Sarah Ehmann; Philipp Harter; Beyhan Ataseven
Journal:  Arch Gynecol Obstet       Date:  2021-03-12       Impact factor: 2.344

Review 2.  The mutational landscape of endometrial cancer.

Authors:  Bo Hong; Matthieu Le Gallo; Daphne W Bell
Journal:  Curr Opin Genet Dev       Date:  2015-01-23       Impact factor: 5.578

3.  Differences in Microsatellite Instability Profiles between Endometrioid and Colorectal Cancers: A Potential Cause for False-Negative Results?

Authors:  Yang Wang; Chanjuan Shi; Rosana Eisenberg; Cindy L Vnencak-Jones
Journal:  J Mol Diagn       Date:  2016-11-01       Impact factor: 5.568

Review 4.  Addressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and Treatment.

Authors:  Michaela A Onstad; Rosemarie E Schmandt; Karen H Lu
Journal:  J Clin Oncol       Date:  2016-11-07       Impact factor: 44.544

5.  Is hormonal therapy after risk-reducing salpingo-oophorectomy associated with an increased risk of malignancy in pathogenic variant carriers?

Authors:  Kathryn A Mills; Tanvi V Joshi; Lindsay West; Michelle Kuznicki; Laura Kent; Alexis N Hokenstad; James C Cripe; Candice Woolfolk; Leigha Senter; Jamie N Bakkum-Gamez; Robert M Wenham; David E Cohn; Victoria Bae-Jump; Premal H Thaker
Journal:  Gynecol Oncol       Date:  2020-03-03       Impact factor: 5.482

6.  Clinical significance of mismatch repair genes immunohistochemical expression of complex endometrial hyperplasia.

Authors:  Su Jin Han; Min Kyu Kim
Journal:  Obstet Gynecol Sci       Date:  2015-03-16

7.  Understanding Molecular Landscape of Endometrial Cancer through Next Generation Sequencing: What We Have Learned so Far?

Authors:  Siti-Syazani Suhaimi; Nurul-Syakima Ab Mutalib; Rahman Jamal
Journal:  Front Pharmacol       Date:  2016-11-01       Impact factor: 5.810

8.  Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: a prospective cohort study in China.

Authors:  Xiaopei Chao; Lei Li; Ming Wu; Shuiqing Ma; Xianjie Tan; Sen Zhong; Yalan Bi; Jinghe Lang
Journal:  Cancer Commun (Lond)       Date:  2019-07-15

9.  Comparison of microsatellite instability detection by immunohistochemistry and molecular techniques in colorectal and endometrial cancer.

Authors:  Franceska Dedeurwaerdere; Kathleen Bm Claes; Jo Van Dorpe; Isabelle Rottiers; Joni Van der Meulen; Joke Breyne; Koen Swaerts; Geert Martens
Journal:  Sci Rep       Date:  2021-06-18       Impact factor: 4.379

10.  Genetic screening in young women diagnosed with endometrial cancer.

Authors:  Basilio Pecorino; Cinzia Rubino; Vito Fabio Guardalà; Antonio Galia; Paolo Scollo
Journal:  J Gynecol Oncol       Date:  2016-09-01       Impact factor: 4.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.